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ABSTRACT
Objectives: To evaluate medical service utilization and medical expendi-
ture associated with obesity-related diseases among different weight status
subjects in Taiwan.
Methods: A cross-sectional survey based on the National Health Inter-
view Survey performed in 2001. Subjects greater than 20 years old who
lived in Taiwan, as corroborated by National Health Insurance (NHI),
during 2001, were included. Overall, the data set included 15,461 subjects
with age of 20–85 years old. After excluding those subjects with incom-
plete or missing data or who refused to link their data with the NHI data,
12,283 subjects were used for analyses.
Results: In general, obesity-related disorders, such as hypertension, dia-
betes mellitus (DM), and cardiovascular diseases have increasing preva-
lence with greater body mass index (BMI; P < 0.001). Obese subjects
(BMI  27 kg/m2) had the highest prevalence of hypertension (31.9%),
after DM (26.9%). After adjusting for age, smoking, drinking and
obesity-related disorders, it was found that medical utilization in outpa-
tient increases from 1.33 to 4.04 visits/year (P < 0.001) and in-hospital
increases from 0.05 to 0.07 admissions/year (P > 0.05) with higher BMI.
Average outpatient expenditure (including physician fee, laboratory test
and drug costs) per year is NT$1201, 1857, 3960, and 5118 (at an
exchange rate of NT$32 to US$1) for underweight, normal, overweight,
and obese subjects, respectively (P < 0.001).
Conclusions: Medical utilization and outpatient medical expenditure was
found to increase with higher BMI status. However, there was a J-shaped
(in female) or even negative (in male) relationship between BMI and
in-hospital medical expenditures. Further studies are needed to resolve this
major public health problem, even in a developing country such as
Taiwan.
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Introduction
Over the past decades, obesity has become a serious global
medical and public health issue, not only in the developed but
also developing countries. In the United States, the prevalence of
obesity and overweight in adults is 72.3% in men and 64.1% in
women [1]; furthermore, the prevalence of adolescents over-
weight increased from 15.1 to 21.7% in boys and 15.2 to 21.1%
in girls from 1963 to 1991 [2]. In Taiwan, according to the
results of the third National Health and Nutrition Examination
Survey, the prevalence of adult obesity is 8.3% to 15.2% (overall
10.5%) in males and 6.9% to 24.8% (overall 13.7%) in females.
Overall, more than one-third of adults are of overweight or obese
status [3]. Many studies have shown that obesity is associated
with increased morbidity and mortality of many chronic diseases
[4–7]. Obese subjects have greater risk for developing cardiovas-
cular diseases, hypertension, type 2 diabetes and stroke than
nonobese subjects [8]. The high prevalence of overweight and
obesity not only has severe impact on human health but also on
the economic burden of countries.
Many studies have demonstrated the association among
obesity, medical expenditure [9–12], and medical utilization
[8,13–15] in developed countries. One health maintenance orga-
nization estimated that the total medical expenditures in subjects
of body mass index (BMI) at 25.0–29.9 kg/m2 and those with
BMI greater than 30 kg/m2 will excess those of BMI of 20.0–
24.9 kg/m2 by 10% and 36%, respectively, in the next 9 years
[9]. The Medical Expenditure Panel Survey (MEPS) showed that
the cost of overweight and obesity was about 9.1% of total
medical expenditure and that it increased with BMI status [10].
The total direct costs attributable to obesity-related conditions
were about US$39.3 billion (5.5% of the total costs of illness).
The highest cost attributable to obesity was from cardiovascular
diseases (US$22.2 billon), and the next highest was from type 2
diabetes (US$11.3 billon) [11]. The obese had higher medical
expenditure and was 2.3% to 22.3% of total medical costs in
England, New Zealand, Sweden, and Japan [16–19]. In Nurses’
Health Study, it was estimated that if obesity prevention program
had began in 1990, it could have saved US$458 billon, about
6.8% of medical expenditure [12]. In many countries, obese
subjects had higher medical utilization, especially outpatient
visits, with increasing BMI status [10,13–15]. The Kaiser Perma-
nente of Colorado demonstrated that the obese had more new
and reﬁll prescription utilization than nonobese. The utilization
of outpatient visits and total direct health cost increased with
age, chronic disease score, and BMI; however, BMI rather than
age was associated with increased risk of hospitalization [20].
In Taiwan, the National Health Insurance (NHI) system is a
social insurance program organized by the government and oper-
ated by the Bureau of National Health Insurance, Department of
Health (DOH), Executive Yuan. More than 99 % of the popu-
lations are enrolled in the compulsory program. The NHI system
offers a comprehensive and uniform package to all those covered
by the program, the insured have access to more than 18,000
contracted health-care facilities around the country, offering out-
patient, inpatient, ambulatory care, and other services. The NHI
is ﬁnanced through a mix of premiums and taxes that compen-
sates the public and private medical delivery systems which are
predominately based on a fee-for-services payment system
[21].
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The purpose of this study is to evaluate medical service uti-
lization and medical expenditure associated with obesity-related
disorders, such as hypertension, diabetes mellitus, cardiovascular
diseases, dyslipidemia, and gout, in Taiwan.
Material and Methods
Study Design and Subjects
This study is a cross-sectional study based on the National
Health Interview Survey (NHIS) performed in 2001. Subjects
greater than 20 years old who lived in Taiwan, as corroborated
by National Health Insurance (NHI), during 2001, were
included. Overall, the data set included 15,461 subjects with age
of 20–85 years old.
The NHIS–Taiwan was a cross-sectional survey that incorpo-
rated a multistage stratiﬁed systematic sampling scheme. Accord-
ing to the geographic locations and degrees of urbanization, it
divided the 359 townships or districts of the Taiwan into seven
strata. After probability proportional to size sampling, four
households were selected at random from each selected
“Lin”—the smallest administrative unit in Taiwan. All household
members were interviewed. In total, 6592 households (26,658
persons) were sampled; the response rate was 91.1% of house-
hold members and 94.2% of households. The details of the
sampling procedure and results are described elsewhere [22].
There were 13,985 subjects, excluding those subjects with
incomplete or missing data such as gender, height, weight, ciga-
rette smoking, or alcohol drinking. Furthermore, 1702 subjects
refused to link their data with the NHI data, so ﬁnally, 12,283
subjects were used for analyses. The schema of study subject
selection (such as inclusion and exclusion process) is presented in
Figure 1.
Deﬁnition of Adverse Behaviors
Subjects were deﬁned as current smokers if they smoked greater
than one cigarette/day during the past 30 days and had smoked
greater than 100 cigarettes in their lifetimes or still had the habit
of smoking.
Subjects were designated as current drinkers if they consumed
greater than two drinks/week of liquor (or equal alcohol concen-
tration) in their lifetimes; designation was based on alcohol con-
centration classiﬁcation, or if they still had the habit of alcohol
drinking at present.
Deﬁnition of Obesity
Various deﬁnitions of obesity among adults in Taiwan exist. The
WHO–Asian’s criteria deﬁned BMI 23–25 kg/m2 as overweight
and BMI greater than 25 kg/m2 as obese. Based on the clinical
practice consideration and for the national characteristics, a
modiﬁed deﬁnition of overweight and obesity was proposed by
the DOH and was applied in; this deﬁnition deﬁnes BMI of less
than 18.5 kg/m2 as underweight, BMI of 18.5–24 kg/m2 as
normal, BMI of 24–27 kg/m2 as overweight, and BMI greater
than 27 kg/m2 as obese [3].
Deﬁnition of Obesity-Related Disorders
In this study, ﬁve diseases, such as hypertension, diabetes melli-
tus, cardiovascular diseases, dyslipidemia, and gout, were iden-
tiﬁed as obesity-related disorders. In addition to self-reported
diseases, the diagnostic codes were extracted from the NHI
records according to the International Classiﬁcation of Disease
9th Revision Clinical Modiﬁcation (ICD-9-CM). The deﬁnition
and criteria of the diseases are as follows: 1) Hypertension: with
the ICD-9 of 401–405, and with anti-hypertensive agents record
appeared in NHI database; 2) Diabetes mellitus: with the ICD-9
of 250, and with antidiabetic agents (such as oral hypoglycemic
agents or insulin) record appeared in NHI database; 3) Cardio-
vascular diseases: with the ICD-9 of 410–414, and with cardio-
vascular agents (such as nitrates or aspirin) record appeared in
NHI database; 4) Dyslipidemia: with the ICD-9 of 272, and with
lipid-lowering agents (such as statins or ﬁbrates) record appeared
in NHI database; and 5) Gout: with the ICD-9 of 274, and with
antigout agents record appeared in NHI database.
Outcome Measurements
In this study, the medical services utilization and expenditure was
based on the claims system of the NHI system during the year of
2001 among the study population. Medical service utilization
includes the frequency of outpatient visits (visits/year) and hos-
pitalization (admissions/year) per person. Medical services
expenditures includes outpatient expenditures (all cost such as
physician fee, examinations, laboratory tests, and prescription
medications) and in-hospital expenditures (including that of sur-
geries, and related expenses such as examinations, laboratory
tests, prescription medications, supplies, nursing care, and hos-
pital rooms).
Statistical Analysis
Mean and standard deviation (SD) were used to describe the
distribution of age, body height, body weight, BMI, medical
Figure 1 Flow chart for inclusion and exclusion of study samples.
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utilization, and expenditures of outpatient and in-
hospitalization. Because of the wide variation of medical utiliza-
tion and expenditure, median was also used to demonstrate the
distribution. Frequency (n) and percentage (%) were used to
determine the distribution of adverse behavior (cigarette smoking
and alcohol drinking) and disease histories (hypertension, diabe-
tes mellitus, cardiovascular diseases, dyslipidemia, and gout). A
chi-square (c2) test was used to compare the association of
obesity-related disorders with different BMI status. Generalized
linear model was used to evaluate the trend of medical utilization
and expenditures with different BMI status after adjusting for
age, cigarette smoking, alcohol drinking and obesity-related dis-
orders. We used Tobit censored model, a two steps approach, to
account for the population with medical utilization and expen-
diture at zero (censored at zero). BMI was transformed as
dummy variable and in one model to examine the trend of
different BMI subgroups. A two-tailed P-value less than 0.05 was
considered statistically signiﬁcant. All statistical analyses were
conducted using the statistical package SAS 8.2 (SAS Institute
Inc, Cary, NC).
Results
The distribution of general characteristics (age, anthropometric,
and adverse behaviors), disease histories (hypertension, diabetes
mellitus, cardiovascular diseases, dyslipidemia, and gout),
medical utilization, and expenditure with gender speciﬁcation are
shown in Table 1. In total, there were 12,283 subjects (6285
males, 51.2%; 5998 females, 48.8%) included in this study, with
a mean age of 41.7 years. In general, male subjects were older,
taller, and heavier, had higher BMI and higher prevalence of
smoking and drinking than female subjects (all P < 0.001). The
overall prevalence of smoking was 29.9 % (52.6% for males,
6.1% for females, P < 0.001) and that of alcohol drinking was
28.0% (44.4% for males, 10.8% for females, P < 0.001). Among
the overall subjects, there were 20.0% with the history of hyper-
tension, 18.8% with diabetes mellitus, 7.3% with dyslipidemia,
9.3% with cardiovascular diseases, and 6.6% with gout. The
prevalence of gout in males was higher than those in females (8.9
vs. 4.1%, P < 0.001). However, females had higher prevalence of
diabetes mellitus (20.1 vs. 17.7%, P < 0.01). The frequency of
outpatient visits and in-hospital admissions were 2.34 visits per
year and 0.05 admissions per year, respectively; the average
outpatient and in-hospital expenditures were NT$2748 dollars
and NT$2646 dollars per year (at an exchange rate of NT$32 to
US$1), respectively. In general, males had higher medical utiliza-
tion and expenditure (both P < 0.001).
Table 2 shows the age-adjusted prevalence of obesity-related
disorders in subjects of different BMI statuses with gender speci-
ﬁcation. It was found that the higher the BMI status, the higher
the prevalence of hypertension, diabetes mellitus, cardiovascular
diseases, and gout. For example, among males, the prevalence of
hypertension was 15.7%, 16.1%, 23.7%, and 26.1% for those
of underweight, normal, overweight, and obese statuses, respec-
tively (P < 0.001). All obesity-related disorders had positive cor-
relation with BMI status (P < 0.001). The disease most prevalent
in obese subjects was hypertension (31.9%), followed by diabe-
tes mellitus (26.9%).
Overall medical utilization, including outpatient and
in-hospital, in subjects of different BMI status, with gender speci-
ﬁcation, are shown in Table 3. After adjusting for age, smoking,
alcohol drinking, and obesity-related disorders, the data in
Table 3 indicated that with higher BMI, medical utilization, in
terms of outpatient use, increases from 1.33 to 4.04 visits/year
(P < 0.001 for trend) and in-hospital use increases from 0.05 to
0.07 admissions/year (P > 0.05 for trend). Among males, the
outpatient medical utilization varied from 2.66 to 3.62 visits/year
for underweight to obese subjects with a statistically signiﬁcant
trend (P < 0.001 for trend). Among females, the underweight
subjects have less outpatient medical utilization than obese sub-
Table 1 General characteristics of study subjects
Total (n = 12,283) Male (n = 6,285) Female (n = 5,998)
Mean SD Mean SD Mean SD
Age (year) 41.69 14.99 42.19 15.42 41.18 14.50‡
Body height (cm) 163.17 8.08 168.78 6.02 157.29 5.32‡
Body weight (kg) 61.93 11.64 67.91 10.59 55.66 9.11‡
BMI (kg/m2) 23.19 3.57 23.82 3.36 22.52 3.67‡
Medical utilization§
Outpatient 2.34 5.53 2.50 5.96 2.17 5.04‡
Median|| (3.00) Median|| (4.00) Median|| (3.00)
In-hospital 0.05 0.37 0.06 0.40 0.05 0.34
Median|| (1.0) Median|| (1.0) Median|| (1.0)
Medical expenditure
Outpatient 2,748 11,229 3,160 12,935 2,317 9,085‡
Median|| (2,094) Median|| (2,539) Median|| (1,731)
In-hospital 2,646 30,158 3,306 37,988 1,954 18,700*
Median|| (33,916) Median|| (32,718) Median|| (37,601)
Adverse behavior n % n % n %
Smoking cigarette 3,669 29.9 3,305 52.6 364 6.1‡
Alcohol drinking 3,435 28.0 2,790 44.4 645 10.8‡
Disease history (ICD9 or drug)
Hypertension 2,462 20.0 1,248 19.9 1,214 20.2
Diabetes mellitus 2,315 18.8 1,111 17.7 1,204 20.1†
Cardiovascular diseases 1,138 9.3 605 9.6 533 8.9
Dyslipidemia 896 7.3 469 7.5 427 7.1
Gout 808 6.6 560 8.9 248 4.1‡
*P < 0.05, †P < 0.01, ‡P < 0.001 when compared with male.
§Medical utilization is deﬁned as visits/year for outpatient and admissions/year for in-hospital; medical expenditure is deﬁned as average NT$/person/year (at an exchange rate of NT$32 to
US$1).
||Median is calculated based on the valid subjects number (exclude those subjects did not use medical services), which are 4291, 2161, and 2130 for total, male, and female, respectively.
BMI, body mass index; SD, standard deviation.
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jects (0.91 vs. 4.70 visits/year). However, there is no signiﬁcant
association between medical utilization (in-hospital) and differ-
ent BMI statuses in females (from 0.03 to 0.07 admissions/year
for underweight to obese, P > 0.05 for the trend).
Table 4 shows the overall medical expenditure, including out-
patient and in-hospital, in subjects of different BMI status, with
gender speciﬁcation. After adjusting for age, smoking, alcohol
drinking and obesity-related disorders, the average outpatient
medical expenditures of all subjects were NT$1201, 1857, 3960,
and 5118 (at an exchange rate of NT$32 to US$1) for under-
weight, normal, overweight, and obese subjects, respectively, per
year (P < 0.001 for trend). However, there is a J-shaped pattern of
in-hospital medical expenditure among different BMI status
female subjects. For males, there is even a negative association
between in-hospital medical expenditure and BMI statuses
(P < 0.05 for trend).
Age-adjusted outpatient and in-hospital medical expenditure
in different BMI statuses, with gender speciﬁcation, are pre-
sented in Figures 2 and 3. For all subjects, there was a positive
association between outpatient expenditures and BMI status
with a statistically signiﬁcantly trend (P < 0.001 for trend).
However, there is a J-shaped association between in-hospital
expenditures and BMI status (P < 0.05). Among males, the
obese subjects have the highest outpatient medical expenditure.
However, unexpectedly, there was a negative association
between in-hospital medical expenditure and male BMI
Table 2 Prevalence of obesity-related disorders in different BMI status with gender speciﬁcation
Underweight Normal Overweight Obesity BMI status
comparison*
Gender
comparison†n % n % n % n %
Total (n = 814) (n = 6909) (n = 2917) (n = 1633)
Hypertension 89 10.9 1086 15.7 766 26.2 521 31.9 336.3 (P < 0.001)
Diabetes mellitus 96 11.8 1124 16.3 656 22.4 439 26.9 150.7 (P < 0.001)
Cardiovascular diseases 47 5.8 492 7.1 368 12.6 231 14.1 134.7 (P < 0.001)
Dyslipidemia 22 2.7 379 5.5 299 10.2 196 12.0 149.9 (P < 0.001)
Gout 25 3.1 297 4.3 276 9.4 210 12.9 218.9 (P < 0.001)
Male (n = 198) (n = 3285) (n = 1809) (n = 993)
Hypertension 31 15.7 530 16.1 428 23.7 259 26.1 71.4 (P < 0.001) 18.9 (P < 0.001)
Diabetes mellitus 26 13.1 494 15 352 19.5 239 24.1 50.4 (P < 0.001) 39.9 (P < 0.001)
Cardiovascular diseases 19 9.6 254 7.7 210 11.6 122 12.3 29.8 (P < 0.001) 5.8 (P = 0.122)
Dyslipidemia 6 3.0 183 5.6 166 9.2 114 11.5 53.6 (P < 0.001) 11.9 (P = 0.008)
Gout 12 6.1 196 6.0 198 10.9 154 15.5 99.6 (P < 0.001) 9.2 (P = 0.026)
Female (n = 616) (n = 3624) (n = 1118) (n = 640)
Hypertension 58 9.4 556 15.3 338 30.2 262 40.9 337.5 (P < 0.001)
Diabetes mellitus 70 11.4 630 17.4 304 27.2 200 31.3 130.6 (P < 0.001)
Cardiovascular diseases 28 4.5 238 6.6 158 14.1 109 17.0 128.8 (P < 0.001)
Dyslipidemia 16 2.6 196 5.4 133 11.9 82 12.8 105.0 (P < 0.001)
Gout 13 2.1 101 2.8 78 7.0 56 8.8 80.2 (P < 0.001)
*Using chi-square test for trend when compared with different BMI statuses.
†Using chi-square test when compared with female.
BMI, body mass index.
Table 3 Outpatient and in-hospital of medical service utilization among different BMI status with gender speciﬁcation
Underweight Normal Overweight Obesity
BMI status comparison*Mean SD Mean SD Mean SD Mean SD
Total (n = 814) (n = 6909) (n = 2927) (n = 1633) F Test
Outpatient 1.33 6.02 1.71 4.53 3.15 6.19 4.04 7.09 16.97 (P < 0.001)
(Median†) (2.0) (3.0) (4.0) (6.0)
In-hospital 0.05 0.34 0.05 0.37 0.07 0.39 0.07 0.39 1.77 (P = 0.150)
(Median†) (1.0) (1.0) (1.0) (1.0)
Male (n = 198) (n = 3285) (n = 1809) (n = 993)
Outpatient 2.66 10.47 1.86 4.86 3.03 6.34 3.62 6.96 11.78 (P < 0.001)
(Median§) (4.5) (3.0) (4.0) (5.0)
In-hospital 0.10 0.41 0.06 0.41 0.06 0.38 0.07 0.40 1.59 (P = 0.189)
(Median§) (1.0) (1.0) (1.0) (1.0)
Female (n = 616) (n = 3624) (n = 1118) (n = 640)
Outpatient 0.91 3.47 1.58 4.21 3.34 5.94 4.70 7.25 5.38 (P = 0.001)
(Median‡) (2.0) (2.0) (4.0) (7.0)
In-hospital 0.03 0.31 0.04 0.32 0.07 0.42 0.07 0.32 1.16 (P = 0.322)
(Median‡) (1.0) (1.0) (1.0) (1.0)
*Using generalized linear model (GLM) test for trend when compared with different BMI status in total, male or female subjects, respectively.After adjusting for age, cigarette smoking, alcohol
drinking and obesity-related disorders.
†Median is calculated based on the valid subjects number (exclude those subjects did not use medical services).
For total outpatient, there are 186, 2064, 1249, and 792 subjects for underweight, normal, overweight, and obesity; for in-hospital, there are 23, 205, 123, and 80, respectively.
‡Median is calculated based on the valid subjects number (exclude those subjects did not use medical services).
For female outpatient, there are 134, 1108, 534, and 354 subjects for underweight, normal, overweight, and obesity; for in-hospital, there are 10, 78, 50, and 34, respectively.
§Median is calculated based on the valid subjects number (exclude those subjects did not use medical services).
For male outpatient, there are 52, 956, 715, and 438 subjects for underweight, normal, overweight, and obesity; for in-hospital, there are 13, 127, 73, and 46, respectively.
Medical utilization for outpatient is deﬁned as visits/year and in-hospital is deﬁned as admissions/year.
BMI, body mass index; SD, standard deviation.
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Table 4 Medical expenditures of outpatient and in-hospital among different BMI status with gender speciﬁcation
Underweight Normal Overweight Obesity
BMI status comparison*Mean SD Mean SD Mean SD Mean SD
Total (n = 814) (n = 6,909) (n = 2,927) (n = 1,633) F Test
Outpatient 1,201 5,359 1,857 7,445 3,960 15,720 5,118 15,625 7.76 (P < 0.001)
(Median†) (946) (1,604) (2,634) (3,732)
In-hospital 3,666 34,718 2,370 33,932 3,014 23,429 2,646 19,634 3.56 (P = 0.014)
(Median†) (50,676) (34,149) (35,870) (26,775)
Male (n = 198) (n = 3,285) (n = 1,809) (n = 993)
Outpatient 2,130 7,236 2,246 9,050 4,243 18,933 4,416 10,878 3.73 (P = 0.011)
(Median‡) (2,490) (2,122) (2,887) (3,600)
In-hospital 9,602 57,882 3,312 45,795 3,085 25,103 2,434 19,394 3.66 (P = 0.012)
(Median‡) (57,981) (33,089) (35,870) (22,503)
Female (n = 616) (n = 3,624) (n = 1,118) (n = 640)
Outpatient 902 4,564 1,505 5,584 3,503 8,170 6,206 20,925 7.08 (P < 0.001)
(Median§) (820) (1,264) (2,388) (3,806)
In-hospital 1,758 22,476 1,515 17,115 2,900 20,441 2,975 20,011 1.66 (P = 0.173)
(Median§) (41,356) (40,009) (36,909) (31,902)
*Using generalized linear model (GLM) test for trend when compared with different BMI status in total, male and female subjects, respectively.After adjusting for age, cigarette smoking, alcohol
drinking and obesity-related disorders.
†Median is calculated based on the valid subjects number (exclude those subjects did not use medical services).
For total outpatient, there are 186, 2064, 1249, and 792 subjects for underweight, normal, overweight, and obesity; for in-hospital, there are 23, 205, 123, and 80, respectively.
‡Median is calculated based on the valid subjects number (exclude those subjects did not use medical services).
For male outpatient, there are 52, 956, 715, and 438 subjects for underweight, normal, overweight, and obesity; for in-hospital, there are 13, 127, 73, and 46, respectively.
§Median is calculated based on the valid subjects number (exclude those subjects did not use medical services).
For female outpatient, there are 134, 1108, 534, and 354 subjects for underweight, normal, overweight, and obesity; for in-hospital, there are 10, 78, 50, and 34, respectively.
Medical expenditure is deﬁned as average NT$/person/year (at an exchange rate of NT$32 to US$1).
BMI, body mass index; SD, standard deviation.
Figure 2 Age-adjusted outpatient medical expenditures among different BMI status with gender speciﬁcation.Outpatient medical expenditures include all cost such
as physician fee, examinations, laboratory tests, and prescription medications (at an exchange rate of NT$32 to US$1).@, P for trend <0.001 when compared with
different BMI status in total subjects. #, P for trend <0.05 when compared with different BMI status in males. €, P for trend <0.001 when compared with different
BMI status in females.
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status (P < 0.05 for trend). Among females, obese subjects had
higher average outpatient medical expenditure than under-
weight subjects (NT$6206 vs. NT$902 dollars, P < 0.05).
There was a J-shaped relationship between in-hospital medical
expenditure and BMI status without statistical signiﬁcance
(P > 0.05).
Discussion
In the past decades, obesity has become a serious public health
problem all over the world. Obesity-related disorders, such as
hypertension, diabetes mellitus, and cardiovascular diseases, are
associated with both medical and economic burdens in developed
countries. This study ﬁnds that higher BMI status is indicative of
greater medical utilization and higher outpatient medical expen-
diture. In males, obese had the highest outpatient medical utiliza-
tion and expenditure when compared to all other subjects. There
was no signiﬁcant association between in-hospital medical utili-
zation with different male BMI statuses. Furthermore, there was
even a negative trend between in-hospital medical expenditures
andmale BMI statuses. In females, therewas a positive association
among outpatient medical utilization, outpatient expenditure and
BMI status. There was no signiﬁcant association among
in-hospital utilization, expenditure, and BMI status in females.
There are some limitations of our study in using a cross-
sectional study design database to evaluate the association
between BMI status and medical utilization and expenditure.
First, in this cross-sectional study design, subjects might have
reduced their weight due to other chronic disorders, causing the
relationship among medical utilization, expenditure, and BMI
status to be attenuated or even with inversely association.
Second, weight and height were self-reported, which suggests
that the BMI may be underestimated and thus the relationship
between BMI and medical utilization and expenditure should be
stronger than observed. Furthermore, abdominal (visceral)
obesity may be a better predictor of the obesity associated dis-
orders or medical utilization, but we did not collect such infor-
mation in this study. Third, although the NHI system covers
more than 99% population in Taiwan, there are still some self-
paid medical services which are not counted in this NHI database
and which may have attenuated our results of the evaluate of the
relationship between BMI status and medical expenditure.
Finally, Taiwan’s NHI system is a very unique heath insurance
coverage system, and our results may not apply to other coun-
tries or areas that conduct similar analyses.
Obesity-Related Disorders and Medical Utilization
Obesity is associated with higher medical utilization [8,13–
15,23]. In National Health and Nutrition Examination Survey-I
Figure 3 Age-adjusted in-hospital medical expenditures among different BMI status with gender speciﬁcation. In-hospital medical expenditures include that of
surgeries, and related expenses such as examinations, laboratory tests, prescription medications, supplies, nursing care, and hospital rooms (at an exchange rate of
NT$32 to US$1). @, P for trend <0.05 when compared with different BMI status in total subjects. #, P for trend <0.05 when compared with different BMI status
in males.
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(NHANES-I), the overweight (BMI  25 kg/m2) subjects had
more outpatient visits than the normal subjects (BMI 18.5–
24.9 kg/m2) [13]. In Canada, according to the National Popula-
tion Health Survey data, the obese subjects had higher stress
scores, more limited activity, lower health condition scores and
poorer self-health conditions, and also more outpatient visits
when compared with normal subjects [8]. In the Long-term Out-
comes of Sibutramine Effectiveness on Weight Study, outpatient
medical service utilization among the obese was 3.85 times higher
than their matched nonobese members [20]. In the Australian
National Health Survey, there was a clear relationship between
BMI category and medical-service utilization among Australian
women. Overweight women in that study had a greater likelihood
of outpatient clinic visiting than those of normal weight [23]. In
our study, after adjusting for potential confounders, there was a
positive relationship between outpatient visits, but not in-hospital
utilization, and BMI status in both men and women. These
ﬁndings were similar to other studies that the obese had higher
outpatient visit. For in-hospital, we only calculated the frequency
of admission, but not the length of hospital stays, which may be
resulted insigniﬁcant ﬁndings in this study.
Obesity-Related Disorders and Medical
Service Expenditure
Many studies have shown that obesity is associated with cardio-
vascular diseases, hypertension, diabetes mellitus, stroke and
some cancers [4–7]. The relationship between obesity-related
disorders and medical expenditure have been discussed in many
developed countries [10,11,17–19,24]. In the United States, the
direct costs of obesity were around US$39.3 billons, about 5.5%
of total medical expenditure, in 1986 [11] and about 6.8% of
health-care expenditure could be attributable to excess body
weight in 1994 [25]. In MEPS, the total cost associated with
overweight and obesity was around US$78.5 billion, about
9.1% of total medical expenditures in 1998 [10]. In England in
1994, the costs for obesity treatments were more than GBP£195
million: about 15% were direct costs and about GB£85.5
million was spend on weight loss products [19]. In New
Zealand, health-care costs attributed to obesity was NZ$135
million, about 2.5% of total health-care costs in the country, in
1991 [16]. In Sweden, the medical costs of overweight and
obesity were US$26.9 billion, about 2.3% of total medical
expenditures, in 2005 [17]. In France, it was estimated that the
cost of obesity amounted to around 2% to 5% of the total cost
of health care in 1992 [26]. According to the data of a Japanese
study, between 1995 and 1998, there was a U-shaped associa-
tion between BMI and total medical costs; furthermore, the total
medical costs of subjects with BMI 25.0–29.9 kg/m2 and
BMI  30.0 kg/m2 was 9.8% and 22.3%, respectively, higher
than those with BMI 21.0–22.9 kg/m2 (about the nadir of the
costs) [18]. In the United States, during 1996 to 1997, after
controlling for age, gender, chronic disease, overall health risk
status, and physical activity level, obese employees had higher
medical costs (US$2151) than overweight (US$1934) and
normal (US$1810) ones [27].
In this study, average outpatient medical expenditure was
NT$2748 and average in-hospital medical expenditure was
NT$2646 per year (at an exchange rate of NT$32 to US$1).
There was a signiﬁcantly increasing trend between BMI status
and outpatient medical expenditure among overall subjects and
in both genders. These ﬁndings were similar to most of the
studies; further researches can focus on the distribution of
medical expenditures in the future to understand which disorders
have higher associated costs, thus providing a better obesity
prevention policy or strategy. However, we found a J-shaped
relationship between BMI status and in-hospital medical expen-
diture for overall subjects and in females which were similar to
the Japan’s study ﬁndings [18]. Furthermore, there was even a
negative association between in-hospital expenditure and BMI
status in males. This behavior may be due to pre-existing diseases
contributing to an overestimate of the real costs associated with
underweight subjects who may be did not consult a doctor until
diseases had worsened, therefore needing to spend more money
on treatment. Furthermore, the underweight subjects may have
other chronic conditions such as cancers or chronic pulmonary
disorders which associated with increased in-hospital expendi-
ture. It would be beneﬁcial if we could identify the presence of
chronic conditions such as cancer or pulmonary disease that
affect weight as well as medical utilization and expenditure.
Collecting such information would not only provide a clearer
picture of the situation, but if collected, could be controlled for in
the regression analyses to give a more informed estimate of costs
by BMI category.
Finally, this study clearly demonstrates the positive associa-
tion between BMI and medical utilization and outpatient expen-
diture suggesting that the medical and economic burden of
obesity and its related disorders is present not only in developed
countries, but also in developing countries, such as Taiwan. This
study shows that the obese subjects were associated with higher
prevalence of obesity-related disorders, such as hypertension,
diabetes mellitus, and cardiovascular diseases. Furthermore, the
obese subjects had higher outpatient visits and medical expendi-
tures when compared with other subjects. This ﬁnding may help
the government make decisions on policies for resources alloca-
tion. Further studies may focus on the evaluation of the cost-
effectiveness of obesity intervention and providing appropriate
obesity management strategies to resolve obesity-related medical
and public health problems.
Source of ﬁnancial support: NSC, Taiwan and Sanoﬁ-Aventis Taiwan Co.,
Ltd.
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